- Home
- BGLC vs CSCI Comparison
BGLC vs CSCI Comparison
Compare BGLC & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- CSCI
- Stock Information
- Founded
- BGLC 2017
- CSCI 1990
- Country
- BGLC Malaysia
- CSCI Canada
- Employees
- BGLC N/A
- CSCI N/A
- Industry
- BGLC Medical Specialities
- CSCI
- Sector
- BGLC Health Care
- CSCI
- Exchange
- BGLC Nasdaq
- CSCI NYSE
- Market Cap
- BGLC 10.7M
- CSCI 10.6M
- IPO Year
- BGLC N/A
- CSCI 1996
- Fundamental
- Price
- BGLC $5.09
- CSCI $3.53
- Analyst Decision
- BGLC
- CSCI
- Analyst Count
- BGLC 0
- CSCI 0
- Target Price
- BGLC N/A
- CSCI N/A
- AVG Volume (30 Days)
- BGLC 2.7M
- CSCI 2.4K
- Earning Date
- BGLC 08-13-2025
- CSCI 08-12-2025
- Dividend Yield
- BGLC N/A
- CSCI N/A
- EPS Growth
- BGLC N/A
- CSCI N/A
- EPS
- BGLC N/A
- CSCI N/A
- Revenue
- BGLC $9,265,870.00
- CSCI $9,030,000.00
- Revenue This Year
- BGLC N/A
- CSCI N/A
- Revenue Next Year
- BGLC N/A
- CSCI N/A
- P/E Ratio
- BGLC N/A
- CSCI N/A
- Revenue Growth
- BGLC N/A
- CSCI 36.51
- 52 Week Low
- BGLC $2.01
- CSCI $1.96
- 52 Week High
- BGLC $15.60
- CSCI $7.43
- Technical
- Relative Strength Index (RSI)
- BGLC 52.61
- CSCI N/A
- Support Level
- BGLC $5.33
- CSCI N/A
- Resistance Level
- BGLC $6.39
- CSCI N/A
- Average True Range (ATR)
- BGLC 1.18
- CSCI 0.00
- MACD
- BGLC 0.10
- CSCI 0.00
- Stochastic Oscillator
- BGLC 19.15
- CSCI 0.00
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.